Fever is a common clinical symptom, often indicative of an underlying pathological process. It is a physiological response to various triggers, such as infection, inflammation, or malignancy. This article aims to provide a comprehensive guide for managing fever in clinical practice, enhancing patient care and outcomes.
Identifying the cause of fever is crucial. A thorough history and physical examination are essential, supplemented by appropriate diagnostic tests. Consider factors such as travel history, exposure to infectious diseases, and recent surgical procedures. Laboratory tests, including complete blood count, blood culture, and imaging studies, can aid in diagnosis.
Treatment should be directed towards the underlying cause. Antipyretics are often used symptomatically, but they do not treat the cause of fever. In infectious cases, antimicrobials are the mainstay of therapy. Inflammatory or autoimmune causes may require corticosteroids or other immunosuppressive agents. It's essential to monitor the patient's response to treatment and adjust accordingly.
Special populations such as infants, the elderly, and immunocompromised individuals require careful consideration. In infants, fever may be the only symptom of serious infection. In the elderly and immunocompromised, fever may be absent despite severe infection. Tailoring the approach to these populations is essential.
While fever itself is not usually harmful, it can lead to complications such as dehydration and delirium, particularly in vulnerable populations. Management should include measures to prevent these complications, such as ensuring adequate hydration and monitoring for signs of confusion or altered mental status.
Managing fever in clinical practice requires a comprehensive approach, including identifying the cause, implementing appropriate treatment strategies, considering special populations, and preventing complications. By understanding and applying these principles, clinicians can effectively manage fever and improve patient outcomes.
1.
Trial Supports Ivonescimab and Chemo for NSCLC Survival
2.
Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.
3.
Lymph node transfer reduces arm swelling after breast cancer surgery, study shows
4.
Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.
5.
Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?
1.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
2.
Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options
3.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
4.
Uncovering the Mysteries of the RDW Blood Test
5.
The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part II
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
3.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
4.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
5.
Navigating the Complexities of Ph Negative ALL - Part XIV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation